2008
Molecular Pathology and Transcriptional Profiling in Early Drug Development
Liedtke C, Pusztai L, Symmans W. Molecular Pathology and Transcriptional Profiling in Early Drug Development. 2008, 47-84. DOI: 10.1002/9780470475959.ch3.Peer-Reviewed Original ResearchNeoadjuvant chemotherapyClinical settingMultigene predictorsBiomarker developmentClinical drugsIntroduction BiomarkersTranscriptional profilingEarly drug developmentMolecular pathologyBiomarkersChanging ParadigmChemotherapyDrug developmentNovel toolDrugsIntriguing modelPredictorsSettingPathologyProfiling
2007
Breast Cancer
Ross J, Linette G, Stec J, Clark E, Ayers M, Symmans F, Hortobagyi G, Pusztai L. Breast Cancer. 2007, 269-278. DOI: 10.1007/978-0-387-33227-7_24.Peer-Reviewed Original ResearchBreast cancerInvasive breast cancerCurrent incidence ratesAmerican womenGenetic predisposition testingMicrometastasis detectionSitu diseaseClinical managementIncidence rateField of pharmacogenomicsRNA expression profilingNew casesPredisposition testingCancerMolecular pathologyBiomarker assaysSerum diagnosticsDiseaseWomenExpression profilingFuture assaysAssaysPathology